Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Chinese Journal of Cancer》 2002-12
Add to Favorite Get Latest Update

Combination Chemotherapy with Taxol and Cisplatin for 57 Patientswith Non-Small Cell Lung Cancer by Intraarteryand Intravenous Infusion

ZHAO Yan, WANG Sen ming, ZHANG JianDepartment of Oncology,Zhujiang Hospital,Guangzhou 510282,P.R.China  
Background Objective: Although previous studies showed that intravenous infusion chemotherapy combined with Taxol and cisplatin(DDP) can improve the effects of the treatment of advanced non small cell lung cancer (NSCLC), the results remained unsatisfactory because of the lower concentration of local chemotherapeutic agent. This study was designed to administrate the chemotherapeutic agents through the local artery and to evaluate the efficacy of the intraartery (IA) and the intravenous (IV) infusion chemotherapy combined Taxol with cisplatin (DDP) in the treatment of NSCLC. Methods: Fifty seven patients with advanced NSCLC were enrolled and randomized into two groups. Group A (27 patients ) was given by IA chemotherapy consisting of Taxol 135 mg/m2 and DDP 80 mg/ m2 within 3 hours in the first day. Group B (30 patients) was given by IV chemotherapy consisting of Taxol 135 mg/m2 and DDP 80 mg/m2 within 3 hours in the first day. The patients in two groups were repeatedly treated every 3~4 weeks for at least 2 cycles. Results: The recent effect was evaluated by the CT or X ray results. Of the 57 patients, 1 case acquired complete response,29 partial response.The overall response rate was 52.63% with 66.67%(18/27) in group A and 40.00% (12/30) in group B.The median TTP was 5.5 months in group A and 4.0 months in group B.The median survival time was 13.5 months in group A and 10.5 months in group B. The 0.5,1,2,and 3 year survival rates were 85.18%,66.67%,48.15%,and 18.51% months in group A,respectively.The 0.5,1,2,and 3 year survival rates were 70.00%,53.33%,30.00%,and 6.67% months in group B,respectively.The main side effects were myelosuppression,gastrointestinal reactions and peripheral neuropathy. They could be effectively treated with large amount of vitamines,antacid,guastil,white blood cell stimulating drugs and liquid compensation. Conclusion:The artery infusion Taxol and DDP chemotherapy is one of the useful methods in the treatment of NSCLC patients.The local response rate in the patients treated by IA may be higher than those treated by IV.
【CateGory Index】: R734.2
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
Chinese Journal Full-text Database 1 Hits
1 GU Yangkui, WU Peihong, ZHAO Ming, et al. Cancer Center, Sun Yat - Sen University, Guangzhou 510060;Comparative study of toxic reactions and pharmacological dynamics of DDP administrated by trans-arterial injection and intravenous infusion in patients with NSCLC[J];Journal of Diagnostic Imaging & Interventional Radiology;2003-01
Chinese Journal Full-text Database 1 Hits
1 ZENG Huiying, LI Huai, SHI Zhonghua, et al. Department of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Medical College, Beijing 100021, China;Infusion chemotherapy and chemoembolization of liver metastases from cancer of the alimentary tract[J];Chinese Journal of Oncology;2000-05
Chinese Journal Full-text Database 10 Hits
1 ZHOU Dai-Han1, LIN Li-Zhu1, ZHOU Yi-Qiang2, LUO Rong-Cheng3, LIU Kui-Feng4, JIA Ying-Jie5, CHEN Ji-Yue6, NIU Xi-Wei2, SU Bi-Ru7, LU Jiang8, WANG Shu-Tang1 1. Cancer Center, The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, 510405, P. R. China 2. Henan Provincial Hospital of Traditional Chinese Medicine, Zhengzhou, Henan, 450002, P. R. China 3 Cancer Center, Southern Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, P. R. China 4. Department of Oncology, The Affiliated Hospital, Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510080, P. R. China 5. Department of Oncology, The First Affiliated Hospital, Tianjin College of Traditional Chinese Medicine, Tianjin, 300193, P. R. China 6. Department of Oncology, The 421 Naval Hospital, Guangzhou, Guangdong, 510318, P. R. China 7. The First Chinese Medicine Factory of Guangzhou, Guangzhou, Guangdong, 510130, P. R. China 8. Jilin Yatai Pharmaceutical Company, LTD., Changchun, Jilin, 130031, P. R. China;Prognostic Analysis of Stage Ⅲ-Ⅳ Non-small Cell Lung Cancer Patients Treated by Traditional Chinese Medicine[J];Chinese Journal of Cancer;2005-10
2 WANG Ji dong,ZHANG Yin xiu,XU Yang,ZHOU Ping (Department of Oncology,Anqing Hospital of PLA Navy,Anhui 246003,China);Vinorelbine plus cisplatin therapy for treatment of advanced non-small cell lung cancer[J];Journal of Bengbu Medical College;2004-01
3 TAO Zhi-rong(Department of Hematology,The First Affiliated Hospital of Bengbu Medical College,Bengbu 233004,China);Application and nursing of TOP transfusion pump in the VAD projet for treating multiple myeloma[J];Journal of Bengbu Medical College;2007-05
4 Liu Zhe, Zhu Yunzhong, Xu Liyan, et al(Department of Medical Oncology and Radiotherapy, Beijing Thoracic Tumor and Tuberculosis Hospital, Beijing 101149);Randomized study of concurrent versus sequential hyperfractionated radiotherapy in combination with cisplatin and etoposide for limited-stage small cell lung cancer[J];Beijing Medical Journal;2005-11
5 Qun-Ying Yang Guang-Chuan Xu Li-Kun Chen Department of medical oncology,,Cancer Cencer,Sun Yat-sen University,Guanzhou 510060,P.R.China;Progress in the Study of Penetration into Blood-brain Barrier of New Anti-lung Cancer Drugs[J];Chinese Journal of Neuro-Oncology;2004-03
6 LI Hong-chen,WANG Wei-ping,ZHUGE Yan-hong(Department of Thoracic Surgery,Lanxi People's Hospital,Lanxi 321100,Zhejiang,China);The effect of parenteral nutrition on the nutritional status and immunity after chemotherapy in lung cancer patients[J];Parenteral & Enteral Nutrition;2012-04
7 LIANG Wen-zhao,JIN Cang-zheng Department of Radiology,Nanhai Hospital,Nanfang Medical University,Foshan City Guangdong 528200,China;Efficacy analysis of emergency treatment for acute hemorrhage due to rupture of progressed liver cancer[J];Contemporary Medicine;2011-30
8 Dong Zi-jun,Zhang Xu,Yang Qing-chun Department of interventional radiology,The east hospital of lianyungang,222042;Combination of docetaxel and cisplatin in the interventional treatment of advanced non,small cell lung cancer:A report of 23 cases[J];Contemporary Medicine;2011-30
9 Lu Wei-kun (Qinzhou City Hospital of Traditional Chinese Medieine,Guangxi,Qinzhou 535000,China);The Clinical Value of CT-guided Percutaneous Comprehensive Targeting Treatment in the Advanced Hepatocellular Carcinoma[J];Chinese Journal of Medicinal Guide;2008-02
10 ZHU Yunzhong , SHI Heling, QIAN Hao, HUANG Wenxia, HONG Zhuan, ZHANG Yiping, XU Nong, ZHANG Li, LIU Donggeng, DONG Zhongsheng, LI Shufen, ZHANG Lijian, ZHENG Wen. Beijing Thoracic Tumor Research Institute, Beijing 101149, P.R.China;The phase Ⅱ clinical trial of Seratia Marcescens Anticancer Vaccine (S311)for malignant pleural effusions[J];Chinese Journal of Lung Cancer;2001-04
Chinese Journal Full-text Database 2 Hits
1 CAI Xiao- ling, CAO Xiao- long, JIANG Bing- fen* , GUO Tian- sheng Department of Oncology, People s Hospital of Panyu, Guangzhou 511400, P.R.China;Bronchial Arterial Infusion of Chemotherapeutic Drugs in Treatment of Patients with Locally Advanced Non- Small Cell Lung Cancer[J];Chinese Journal of Cancer;2001-04
2 ZHAN Yongzi, HUANG Changjie, HUANG Jianfeng, WANG Xiangping. Department of Oncology, The Third Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi 530031, P.R.China;Combination of gemcitabine and carboplatin in the treatment of advanced non-small cell lung cancer[J];Chinese Journal of Lung Cancer;2004-02
【Secondary References】
Chinese Journal Full-text Database 6 Hits
1 CUI Guo-xiang,WANG Fei-zhou,BAO Xi-fu,ZHENG Shu-guang,SUN Yi (1.Department of Radiology,the Second People's Hospital of Dalian,Dalian 116011,China;2.The Hygiene Prevention and Cure Station of Zhongshan Distrct Dalian,Dalian 116001,China;3.Department of Radiology,Chemical Group Hospital of Dalian,Dalian 116031,China);Intra-Arterial therapy on 78 pulmonary carcinoma patients image department[J];Journal of Dalian Medical University;2006-04
2 An Xiao,Xiao Xiangsheng (Department of Radiology,Shanghai Changzheng Hospital,Second Military Medical University);Research for Carboplatin Pharmacokinetics during Bronchial Artery Infusion Chemotherapy on the Basis of Microdialysis Technique[J];Journal of Capital Medical University;2007-06
3 CAO Xiao-juan1, YU Guo-zheng2 1Department of Medicine, Railway Hospital of Xi'an, Xi'an 710004, China;2Shaanxi Cancer Hospital ,Xi'an 710061,China.;Clinical study of 654-2 injection in bronchial artery infusion chemotherapy of non-small cell lung cancer[J];Journal of Modern Oncology;2008-10
4 ;Current Status in Interventional Treatment of Lung Cancer through Bronchial Artery[J];Journal of Practical Radiology;2008-05
5 LI Yanan,WANG Wenfeng,WAN Zhenglan;ANALYSIS OF ANTICANCER DRUGS FROM 2008 TO 2009 OF OUR HOSPITAL[J];Modern Hospital;2011-01
6 QIAN Yuan-xin, CHEN Wei. Department of Radiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080;Clinical observation of trans-artery infusion chemotherapy with carboplatin or cisplatin in advanced non-small-cell lung cancer[J];Journal of Diagnostic Imaging & Interventional Radiology;2007-03
【Secondary Citations】
Chinese Journal Full-text Database 1 Hits
1 Su De-Hua et al Department of Medicine, Jiaagxi Tumor Hospital;Carboplatin Combined Etoposide in the Treatment of Lung Cancer[J];Chinese Journal of Clinical Oncology;1994-03
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved